FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

SHOLTIS MARTYN R
2. Issuer Name and Ticker or Trading Symbol

ROCHESTER MEDICAL CORPORATION [ ROCM ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Corporate Vice President
(Last)          (First)          (Middle)

ONE ROCHESTER MEDICAL DRIVE
3. Date of Earliest Transaction (MM/DD/YYYY)

2/28/2013
(Street)

STEWARTVILLE, MN 55976
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

3/4/2013 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock                  41500   (1) (2) D    
Common Stock   2/28/2013     S    1500   D $14.802   (3) 40000   D    
Common Stock   3/1/2013     M    12000   (4) A $4.625   52000   D    
Common Stock   3/1/2013     M    3000   (4) A $4.70   55000   D    
Common Stock   3/1/2013     S    15000   D $14.75   40000   (1) D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)   $4.625   3/1/2013     M         12000   (4)   1/2/2005   (5) 1/2/2014   Common Stock   12000   $0.00   0   D    
Stock Option (Right to Buy)   $4.70   3/1/2013     M         3000   (4)   1/1/2006   (5) 1/1/2015   Common Stock   30000   $0.00   27000   D    
Stock Option (Right to Buy)   $5.70                    1/26/2007   (5) 1/26/2016   Common Stock   20000     20000   D    
Stock Option (Right to Buy)   $12.30                    11/21/2007   (5) 11/21/2016   Common Stock   20000     20000   D    
Stock Option (Right to Buy)   $11.23                    2/6/2009   (5) 2/6/2018   Common Stock   20000     20000   D    
Stock Option (Right to Buy)   $11.27                    2/3/2010   (5) 2/3/2019   Common Stock   20000     20000   D    
Stock Option (Right to Buy)   $12.27                    1/28/2011   (5) 1/28/2020   Common Stock   20000     20000   D    
Stock Option (Right to Buy)   $10.72                    1/27/2012   (5) 1/27/2021   Common Stock   20000     20000   D    

Explanation of Responses:
( 1)  Includes restricted stock award shares.
( 2)  The amount of shares held has been adjusted to reflect an increase of 1,500 shares reported on a Form 4 reporting a 2011 purchase filed concurrently with this amendment. These shares were also omitted from one interim Form 4 filed in December 2012.
( 3)  The price in Column 4 is a weighted average. The prices actually received ranged from $14.79 to $14.85. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
( 4)  Amends incorrect share and option amounts reported on a Form 4 filed March 4, 2013. Total options exercised were 15,000 not 16,500 as reported on prior filing.
( 5)  Vest as to 25% annual cumulative installments beginning one year from date of grant, beginning the date shown.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
SHOLTIS MARTYN R
ONE ROCHESTER MEDICAL DRIVE
STEWARTVILLE, MN 55976


Corporate Vice President

Signatures
David A. Jonas as power-of-attorney for Martyn R. Sholtis 3/4/2013
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Rochester Medical Corp. (MM) (NASDAQ:ROCM)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas Rochester Medical Corp. (MM).
Rochester Medical Corp. (MM) (NASDAQ:ROCM)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas Rochester Medical Corp. (MM).